Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals

AIDS

Volumn 15, Issue 2, 2001, Pages 161-169

  Nokta, M A ^a   Li, X D ^a   Nichols, J ^a   Mallen, M ^a   Pou, A ^a   Asmuth, D ^a   Pollard, R B ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

CCR5; CD4; Chemokine receptors; CXCR4; HIV; Lymph nodes; T cells

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ADULT; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPH NODE BIOPSY; MALE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RECEPTOR DENSITY; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, CCR5; RECEPTORS, CXCR4; VIRAL LOAD; VIRUS REPLICATION;

EID: 0035951462     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200101260-00004     Document Type: Article

References (62)

1. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G proteincoupled receptor
2. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1
3. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
4. Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1)
5. Identification of a major coreceptor for primary isolates of HIV-1
6. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
7. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
8. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1
9. Chemokine receptors: Gateways to inflammation and infection
10. Beta-chemokine inhibition of monocytotropic HIV-1 infection. Interference with a postbinding fusion step
11. CD4-dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR-5
12. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
13. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T cell-line-adapted HIV-1
14. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
15. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
16. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1
17. Expression of chemokine receptors CXCR4 and CCR5 in HIV-infected and uninfected individuals
18. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection
19. NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection
20. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
21. Lymphoid organs function as major reservoirs for human immunodeficiency virus
22. Analysis of human immunodeficiency virus-infected tissues by amplification in situ hybridization reveals latent and permissive infections at singlecell resolution
23. Determination of CD4 antigen density on cells: Role of antibody valency, avidity, clones, and conjugation
24. Flow cytometric quantitation of immunofluorescence intensity: Problems and perspective
25. Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator
26. Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays
27. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
28. Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage
29. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection
30. Differential expression of phenotypic markers of immune activation: Relationship to HIV plasma and cellular viral load in peripheral blood (PB) and lymph node (LN) of HIV-infected individuals
31. + T-cell renewal in early HIV-1 infection: Effect of highly active antiretroviral therapy
32. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
33. + lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues
34. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
35. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1
36. CCR5 levels and expression pattern correlate with infectabillty by macrophage-tropic HIV-1, in vitro
37. Association between CCR5 genotype and the clinical course of HIV-1 infection
38. HIV-1 infected long-term slow progressors heterozygous for Δ32-CCR5 show significantly lower plasma viral load than wild-type slow progressors
39. Impact of heterozygosity for the chemokine receptor CCR5-32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age
40. + lymphocytes from exposed-uninfected individuals: Association with low expression of CCR5 and high production of βchemokines
41. + T cells
42. Dual effect of interleukin 4 on HIV-1 expression: Implication for viral phenotypic switch and disease progression
43. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes
44. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor
45. lckcomplex in the endoplasmic reticulum
46. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane
47. Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV
48. Serine phosphorylation-independent downregulatlon of cell-surface CD4 by nef
49. HIV F/3′orf encodes a phosphorylated GTP-binding protein resembling an oncogene product
50. CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals
51. Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication
52. Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus
53. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV
54. HIV-1 infection abolishes CD4 biosynthesis but not CD4 mRNA
55. + T cells by a complex of the 110K viral protein and the T4 molecule
56. Epitopes of the CD4 antigen and HIV infection
57. The CD4 receptor does not internalize with HIV, and CD4 related signal transduction events are not required for entry
58. Distinct biologic and serologic properties of HIV isolates from the brain
59. Human immunodeficiency virus infection of the CNS: Characterization of 'neutrotropic' strains
60. Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression
61. The biologic and molecular properties of the AIDS-associated retrovirus that affect antiviral therapy